A Resource for Healthcare and Social Services Professionals
The New York Times’ writer, Abby Goodnough, provides a stirring article on recent developments pertaining to the Biden Administration’s support for harm reduction programs. Goodnough captivates readers with an elaborate discussion on Federal funding for “evidence-based harm reduction programs,” while also focusing on the impacts of the trickle-down effects of the pandemic and the perpetuation of stigma on individuals with substance use disorders.
To read the full article, click here.
Grayken Center for Addiction TTA is a program of Boston Medical Center (BMC), a 514-bed academic medical center located in Boston's historic South End and the largest safety-net hospital in New England.
The content on this site and the content presented by Grayken Center for Addiction TTA is intended solely to inform and educate healthcare and social service professionals, and shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional. The hospital, the program, and the contributors are not acting as health care providers or professional consultants on behalf of any specific patient and disclaim establishing a provider-patient relationship with any specific patient.